VIL to sell Mehsana facility to Foseco India for about INR 43.25 crore

Strategic Transactions View source PDF Explain this filing

VESUVIUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹440.80

prior close

₹440.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-1.8% vs market

Electrodes & Refractories peers, median of 10sector+0.3%-2.1% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 2.1 pts less than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+1.0

15m

+0.9

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8+0.1-1.8+0.3-2.1

Next day

+0.0+0.2-0.2-0.2+0.3

-2.4+0.6-3.0+0.3-2.8

-1.8-0.0-1.8-0.3-1.4

-2.5+0.5-3.0+0.4-2.8

-0.2+0.8-1.0-0.3+0.1

-2.8+0.6-3.4-0.2-2.6

15d

-4.8+1.3-6.0-0.7-4.1

-8.3-1.4-7.0-5.2-3.1

-7.7-0.6-7.1-3.4-4.2

—————

UpDownMarket · Nifty Microcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

VIL board approved sale of its Mehsana manufacturing facility (crucibles, stoppers and sleeves for the non-ferrous sector) to fellow subsidiary Foseco India via slump sale for a lump sum of INR 43.25 crore. The facility, described as non-core to VIL, contributed 2.8 percent of revenue (INR 58.13 cr) and 2.09 percent of net worth. Foseco India is a related party, both being fellow subsidiaries of Vesuvius plc UK. Transaction carried out at arm's length basis as certified by independent valuer. Expected completion by 31 December 2026. No impact on shareholding.

Likely market impact

Monetisation of a small non-core asset via a related-party deal at arm's length. Likely neutral to mildly positive for shareholders.